MENU
ONC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BeiGene (ONC) Ownership - Who owns BeiGene?
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
27.14B
P/E Ratio
N/A
Total Cash
2.52B
Projected Growth
N/A
Total Debt
996.83M
Revenue
4.18B
Risk (Beta)
0.65
Dividend Yield
N/A
Total Cash/Share
23.31
Total Debt/Equity
N/A
Revenue/Share
39.02 USD as % of share price
Fundamentals
ONC
Capitalization
27.1B
P/E Ratio
N/A
Risk (Beta)
0.65
Dividend Yield
N/A
Total Cash
2.52B
Total Cash/Share
23.31
Total Debt
997M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
39.02%
Revenue
4.18B
ROE
N/A
Book Value
3.5B
P/B Ratio
7.19
Cash Flow
N/A
Earnings
-3.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
140K
Current Ratio
1.96
Current Revenue Per Employee
101570.82
Dividends Per Share - Security
N/A
EBITDA
-116.48M
Float
N/A
Float - Current
N/A
Gross Income Margin
85.23
Revenue To Assets
-6.82
Shares Held By Institutions
24.3B
Shares Outstanding - Current
108M
Total Liabilities
2.34B
Total Volume MTD
N/A
Value
N/A
Gain YTD
26.279
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A